Skip to Content
Merck
CN

SML2641

Methenamine hippurate

≥95% (HPLC)

Synonym(s):

Hexamethylenetetramine monohippurate, 1,3,5,7-Tetraazatricyclo[3.3.1.13,7]decane N-Benzoylglycine, Hippuric acid, compd. with hexamethylenetetramine (1:1)

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C6H12N4 · C9H9NO3
CAS Number:
5714-73-8
Molecular Weight:
319.36
UNSPSC Code:
12352116
NACRES:
NA.77
MDL number:
MFCD00072147

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Methenamine hippurate, ≥95% (HPLC)

InChI

1S/C9H9NO3.C6H12N4/c11-8(12)6-10-9(13)7-4-2-1-3-5-7;1-7-2-9-4-8(1)5-10(3-7)6-9/h1-5H,6H2,(H,10,13)(H,11,12);1-6H2

SMILES string

OC(CNC(C1=CC=CC=C1)=O)=O.N2(CN(C3)C4)CN3CN4C2

InChI key

ROAIXOJGRFKICW-UHFFFAOYSA-N

assay

≥95% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

H2O: 2 mg/mL, clear

storage temp.

2-8°C

Looking for similar products? Visit Product Comparison Guide

Biochem/physiol Actions

Methenamine hippurate is a broad-spectrum urinary tract antiseptic drug. The methenamine component is hydrolyzed to formaldehyde in acid urine. Hippuric acid acts to keep the urine acid.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000501694
0000502177
0000501694
0000502177
0000166328

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Tze Shien Lo et al.
Expert review of anti-infective therapy, 12(5), 549-554 (2014-04-03)
In the era of multidrug resistance, it is critical to utilize antibiotics in an appropriate manner and to identify new treatments or revisit the use of 'forgotten' drugs. Because urinary tract infections (UTIs) are common, particularly in an increasing elderly
Maria E Terlizzi et al.
Frontiers in microbiology, 8, 1566-1566 (2017-09-02)
Urinary tract infections (UTIs) are one of the most common pathological conditions in both community and hospital settings. It has been estimated that about 150 million people worldwide develop UTI each year, with high social costs in terms of hospitalizations
Cathy Davis et al.
British journal of nursing (Mark Allen Publishing), 26(9), S12-S19 (2017-05-12)
In her lifetime, a woman is highly likely to develop at least one lower urinary tract infection. Early detection and treatment are key. Being aware of predisposing factors for infection and understanding appropriate diagnosis and treatment regimens will help nurses

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service